{"id":1556,"date":"2024-07-05T10:19:47","date_gmt":"2024-07-05T02:19:47","guid":{"rendered":"https:\/\/vcro.online\/?p=1556"},"modified":"2024-07-15T15:16:10","modified_gmt":"2024-07-15T07:16:10","slug":"great-news-tcr-t-cell-therapy-for-hpv-related-solid-tumors-has-received-fda-approval-for-phase-i-ii-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1556","title":{"rendered":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials."},"content":{"rendered":"\n

VCRO\u2019s professional team assisted in preparing the submission to the US FDA for a clinical trial of client\u2019s TCR-T cell therapy product targeting HPV-related solid tumors. In early July 2024, they received FDA approval to initiate Phase I\/II clinical trials, thereby successfully enabling our client to conduct both phases within a single trial design.
 
With extensive experience in the field of cell therapy spanning over many years since 2008, VCRO has accumulated a portfolio of more than 47 projects. Our wealth of experience ensures clients benefit from comprehensive clinical strategy planning and smooth execution processes.<\/p>\n\n\n

\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

VCRO\u2019s professional team assisted in preparing the submission to the US FDA for a clinical trial of client\u2019s TCR-T cell therapy product targeting HPV-related solid tumors. In early July 2024, they received FDA approval to initiate Phase I\/II clinical trials, thereby successfully enabling our client to conduct both phases within a single trial design. With extensive […]<\/p>\n","protected":false},"author":1,"featured_media":1705,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vcro-express"],"yoast_head":"\r\nGreat news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO<\/title>\r\n<meta name=\"description\" content=\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1556\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1556\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2024-07-05T02:19:47+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-15T07:16:10+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials.\",\"datePublished\":\"2024-07-05T02:19:47+00:00\",\"dateModified\":\"2024-07-15T07:16:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556\"},\"wordCount\":115,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg\",\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1556\",\"name\":\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg\",\"datePublished\":\"2024-07-05T02:19:47+00:00\",\"dateModified\":\"2024-07-15T07:16:10+00:00\",\"description\":\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1556\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1556#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO","description":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1556","og_locale":"en_US","og_type":"article","og_title":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO","og_description":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1556","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2024-07-05T02:19:47+00:00","article_modified_time":"2024-07-15T07:16:10+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg","type":"image\/jpeg"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1556#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials.","datePublished":"2024-07-05T02:19:47+00:00","dateModified":"2024-07-15T07:16:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556"},"wordCount":115,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg","articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1556","url":"https:\/\/www.vcro.com.tw\/?p=1556","name":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg","datePublished":"2024-07-05T02:19:47+00:00","dateModified":"2024-07-15T07:16:10+00:00","description":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials. VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1556#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1556"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=1556#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/3797bc01-8246-4d75-a64e-51eb60d6bf03.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1556#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Great news! TCR-T Cell therapy for HPV-related solid tumors has received FDA approval for Phase I\/II clinical trials."}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1556"}],"version-history":[{"count":2,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1556\/revisions"}],"predecessor-version":[{"id":1706,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1556\/revisions\/1706"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1705"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}